Home » Topics » BioWorld

BioWorld
RSS

REPLIGEN ACQUIRES MANUFACTURING FACILITY

Jan. 6, 1992

THE YEAR AHEAD: HOT MARKET FUELS BARGAINING POWER

Jan. 6, 1992

LIPOSOME CO. ISSUES PATENT WARNING

Jan. 6, 1992

THE YEAR AHEAD: ANALYSTS MAKE THEIR PICKS

Jan. 3, 1992

GENELABS SUBSIDIARY BUYS DBL STOCK

Jan. 3, 1992

ECOGEN RAISES $9.5 MILLION

Jan. 3, 1992

ANALYST LOWERS CHIRON RATING

Jan. 3, 1992

GLYCOMED COMPOUND DESIGNATED ORPHAN DRUG

Jan. 3, 1992

LEUKINE APPROVED FOR SECOND INDICATION

Jan. 3, 1992

LIPO GETS PATENT FOR ENCAPSULATION

Jan. 3, 1992

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...